Lexaria Bioscience Corp.

Ownership Transactions Reported by 11 Insiders

Symbol
LEXX, LEXXW on Nasdaq
Location
100 740 Mccurdy Road, Kelowna, British Columbia, Canada

Insiders trading volume in the past year

Lexaria Bioscience Corp. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Christopher Bunka Chief Executive Officer, Director $1.1M Apr 26, 2024
John Docherty President, Director $113K Apr 26, 2024
William McKechnie Director $15.2K Jul 26, 2024
Nicholas Baxter Director $12.7K Jul 26, 2024
Albert Reese Director $12.6K Jul 26, 2024
Catherine C. Turkel Director $9.7K +$5.01K +107% Aug 12, 2024
Gregory Downey Chief Financial Officer $4.08K Oct 14, 2022
Vanessa Carle Secretary $0 -$10.3K -100% Jul 31, 2024
Nelson Cabatuan Chief Financial Officer Mar 14, 2024
Michael Shankman Chief Financial Officer Oct 1, 2024
Richard Christopher Chief Executive Officer Aug 31, 2024

Recent Insider Transactions by Companies or Individuals for Lexaria Bioscience Corp.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.